Avalo Therapeutics Inc (AVTX): IF the drugs are approved, it will be se...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	3
Posts	52
Boards Moderated	0
Alias Born	08/30/2013

Sampall

Re: PennyPusher786 post# 585

Monday, 09/25/2023 11:52:21 AM

Monday, September 25, 2023 11:52:21 AM

IF the drugs are approved, it will be several years in the future.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent AVTX News

Avalo Therapeutics Appoints Biotech Leaders to Board of Directors • GlobeNewswire Inc. • 04/02/2024 11:00:00 AM
Avalo Reports 2023 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 03/29/2024 08:01:00 PM
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million • GlobeNewswire Inc. • 03/27/2024 08:01:00 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/15/2024 02:13:42 AM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 03:02:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 09:01:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 10:05:25 PM
Avalo Therapeutics Announces 1-for-240 Reverse Stock Split • GlobeNewswire Inc. • 12/27/2023 12:00:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/21/2023 09:05:31 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/21/2023 09:01:43 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:01:36 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/07/2023 12:02:48 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 12:01:08 PM
Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split • GlobeNewswire Inc. • 12/07/2023 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 12:15:21 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 12:21:07 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 12:04:55 PM
Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 11/09/2023 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 11:21:15 AM
Avalo Completes Divestiture of AVTX-800 Series • GlobeNewswire Inc. • 10/31/2023 11:00:00 AM
Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 10/19/2023 08:15:07 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/19/2023 08:06:17 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/19/2023 08:01:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2023 08:02:27 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/05/2023 08:02:01 PM

More AVTX News

InvestorsHub NewsWire

FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover